Bonnie L. Bassler - 05 Aug 2021 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Bonnie L. Bassler
Issuer symbol
REGN
Transactions as of
05 Aug 2021
Net transactions value
-$532,477
Form type
4
Filing time
06 Aug 2021, 16:02:48 UTC
Previous filing
02 Jul 2021
Next filing
17 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Options Exercise $1,002,923 +2,559 +287% $391.92 3,450 05 Aug 2021 Direct F1
transaction REGN Common Stock Sale $1,535,400 -2,559 -74% $600.00 891 05 Aug 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction REGN Non-Qualified Stock Option (right to buy) Options Exercise $0 -2,559 -33% $0.000000 5,118 05 Aug 2021 Common Stock 2,559 $391.92 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
F2 The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.